New Transcription Factors and Their Role in Diabetes and Therapy - 1st Edition - ISBN: 9780444511584, 9780080463551

New Transcription Factors and Their Role in Diabetes and Therapy, Volume 5

1st Edition

Editors: Jacob Friedman
eBook ISBN: 9780080463551
Hardcover ISBN: 9780444511584
Imprint: Elsevier Science
Published Date: 10th August 2006
Page Count: 332
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

  1. PPARs as therapeutic targets for treating diabetes and insulin resistance
  2. Genetic regulators of human obesity and diabetes
  3. NF-kb, insulin resistance and the actions of salicylates
  4. Wnt signaling and C/EBPs role in adipogenesis
  5. Regulation of hepatic gluconeogenesis C/EPBs
  6. Forkhead proteins and regulation of hepatic gene expression
  7. Control of mitochondrial biogenesis through PGC-1
  8. Regulation of PGC-1 in humans in insulin resistance and diabetes: Functional implications
  9. FOXC2 controls resistance to obesity and Type II diabetes
  10. SREB-1C regulation of nutrient homeostasis and lipid accumulation
  11. GATA proteins as molecular gatekeeprs of the adipocyte
  12. Diabetes regulation of gene expression by CREB
  13. Molecular etiologies of MODY and other early-onset forms of diabetes
  14. Liver X receptors as potential drug targets for Diabetes and its disorders
  15. The potential therapeutic use of PPAR beta/delta agonists in lipid and glucose homeostasis
  16. Influences of new PPAR insulin sensitizers on the metabolic syndrome in Rhesus Monkeys
  17. PPARgamma and metabolism: Insights from the study of human genetic variants


This book contains contributions from some of the most eminent experts in the fields of genetics, biochemistry, and pathophysiology of diabetes. Through specific examples, with broad applications, this book provides a comprehensive look at how transcription factors may underline the pathogenetic mechanisms of diabetes and obesity.

Volume 5 provides an overview of the status of the field, while also providing valuable information of practical utility to those who do not necessarily work in this field. The integration of basic biology with physiologically and clinically relevant proteins should provide the reader with a theoretical background to understanding the strategies for new potential therapeutic targets and their application to disease.

Key Features

Applies molecular biology to transcriptional regulation of metabolism and obesity Underscores the clinical relevance of transcription factors *Provides a valuable overview of the current status of the field


Endocrinologists, Biomedical researchers, Geneticists, Molecular and Cellular Biologists


No. of pages:
© Elsevier Science 2006
Elsevier Science
eBook ISBN:
Hardcover ISBN:

Ratings and Reviews

About the Editors

Jacob Friedman Editor

Affiliations and Expertise

University of Colorado Health Sciences Center, Denver, CO, USA